AAAAAA
Results: 26-39/39
Authors:
AJANI JA
ILSON DH
KELSEN DP
Citation: Ja. Ajani et al., THE ACTIVITY OF PACLITAXEL IN GASTROINTESTINAL TUMORS, Seminars in oncology, 22(5), 1995, pp. 46-50
Authors:
AJANI JA
ILSON DH
DAUGHERTY K
KELSEN DP
Citation: Ja. Ajani et al., PACLITAXEL IN THE TREATMENT OF CARCINOMA OF THE ESOPHAGUS, Seminars in oncology, 22(3), 1995, pp. 35-40
Authors:
NABEYA Y
LOGANZO F
MASLAK P
LAI L
DEOLIVEIRA AR
SCHWARTZ GK
BLUNDELL ML
ALTORKI NK
KELSEN DP
ALBINO AP
Citation: Y. Nabeya et al., THE MUTATIONAL STATUS OF P53 PROTEIN IN GASTRIC AND ESOPHAGEAL ADENOCARCINOMA CELL-LINES PREDICTS SENSITIVITY TO CHEMOTHERAPEUTIC-AGENTS, International journal of cancer, 64(1), 1995, pp. 37-46
Authors:
KELSEN DP
ILSON DH
Citation: Dp. Kelsen et Dh. Ilson, CHEMOTHERAPY AND COMBINED-MODALITY THERAPY FOR ESOPHAGEAL CANCER, Chest, 107(6), 1995, pp. 224-232
Authors:
ILSON DH
SIROTT M
SALTZ L
HEELAN R
HUANG Y
KERESZTES R
KELSEN DP
Citation: Dh. Ilson et al., A PHASE-II TRIAL OF INTERFERON-ALPHA 2A, 5-FLUOROURACIL, AND CISPLATIN IN PATIENTS WITH ADVANCED ESOPHAGEAL-CARCINOMA, Cancer, 75(9), 1995, pp. 2197-2202
Authors:
AJANI JA
ILSON DH
DAUGHERTY K
PAZDUR R
LYNCH PM
KELSEN DP
Citation: Ja. Ajani et al., ACTIVITY OF TAXOL IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF THE ESOPHAGUS, Journal of the National Cancer Institute, 86(14), 1994, pp. 1086-1091
Authors:
CASPER ES
GREEN MR
KELSEN DP
HEELAN RT
BROWN TD
FLOMBAUM CD
TROCHANOWSKI B
TARASSOFF PG
Citation: Es. Casper et al., PHASE-II TRIAL OF GEMCITABINE (2,2'-DIFLUORODEOXYCYTIDINE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS, Investigational new drugs, 12(1), 1994, pp. 29-34
Authors:
KELSEN DP
Citation: Dp. Kelsen, ESOPHAGEAL CANCER - INTRODUCTION, Seminars in oncology, 21(4), 1994, pp. 401-402
Authors:
ILSON DH
KELSEN DP
Citation: Dh. Ilson et Dp. Kelsen, COMBINED-MODALITY THERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER, Seminars in oncology, 21(4), 1994, pp. 493-507
Authors:
KELSEN DP
SALTZ L
COHEN AM
YAO TJ
ENKER W
TONG W
TAO Y
BERTINO JR
Citation: Dp. Kelsen et al., A PHASE-I TRIAL OF IMMEDIATE POSTOPERATIVE INTRAPERITONEAL FLOXURIDINE AND LEUCOVORIN PLUS SYSTEMIC 5-FLUOROURACIL AND LEVAMISOLE AFTER RESECTION OF HIGH-RISK COLON-CANCER, Cancer, 74(8), 1994, pp. 2224-2233
Authors:
RAO PH
MATHEW S
LAUWERS G
RODRIGUEZ E
KELSEN DP
CHAGANTI RSK
Citation: Ph. Rao et al., INTERPHASE CYTOGENETICS OF GASTRIC AND ESOPHAGEAL ADENOCARCINOMAS, Diagnostic molecular pathology, 2(4), 1993, pp. 264-268
Authors:
MINSKY BD
COHEN AM
KEMENY N
ENKER WE
KELSEN DP
SCHWARTZ G
SALTZ L
DOUGHERTY J
FRANKEL J
WISEBERG J
Citation: Bd. Minsky et al., PREOPERATIVE COMBINED 5-FU, LOW-DOSE LEUCOVORIN, AND SEQUENTIAL RADIATION-THERAPY FOR UNRESECTABLE RECTAL-CANCER, International journal of radiation oncology, biology, physics, 25(5), 1993, pp. 821-827
Authors:
ALTORKI N
SCHWARTZ GK
BLUNDELL M
DAVIS BM
KELSEN DP
ALBINO AP
Citation: N. Altorki et al., CHARACTERIZATION OF CELL-LINES ESTABLISHED FROM HUMAN GASTRIC-ESOPHAGEAL ADENOCARCINOMAS - BIOLOGIC PHENOTYPE AND INVASION POTENTIAL, Cancer, 72(3), 1993, pp. 649-657
Authors:
MINSKY BD
COHEN AM
KEMENY N
ENKER WE
KELSEN DP
SALTZ L
FRANKEL J
Citation: Bd. Minsky et al., THE EFFICACY OF PREOPERATIVE 5-FLUOROURACIL, HIGH-DOSE LEUCOVORIN, AND SEQUENTIAL RADIATION-THERAPY FOR UNRESECTABLE RECTAL-CANCER, Cancer, 71(11), 1993, pp. 3486-3492